168 related articles for article (PubMed ID: 31435668)
1. LncRNA MIR4435-2HG is a potential early diagnostic marker for ovarian carcinoma.
Gong J; Xu X; Zhang X; Zhou Y
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):953-959. PubMed ID: 31435668
[TBL] [Abstract][Full Text] [Related]
2. lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1.
Zhang H; Meng H; Huang X; Tong W; Liang X; Li J; Zhang C; Chen M
Oncol Lett; 2019 Oct; 18(4):4016-4021. PubMed ID: 31516603
[TBL] [Abstract][Full Text] [Related]
3. MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1.
Shen H; Sun B; Yang Y; Cai X; Bi L; Deng L; Zhang L
Odontology; 2020 Oct; 108(4):553-559. PubMed ID: 32016787
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells.
Yang M; He X; Huang X; Wang J; He Y; Wei L
Environ Toxicol; 2020 May; 35(5):582-590. PubMed ID: 31875359
[TBL] [Abstract][Full Text] [Related]
5. LINK-A lncRNA promotes migration and invasion of ovarian carcinoma cells by activating TGF-β pathway.
Ma J; Xue M
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061183
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA MIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression.
Ma DM; Sun D; Wang J; Jin DH; Li Y; Han YE
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2616-2624. PubMed ID: 32196611
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a.
Kong Q; Liang C; Jin Y; Pan Y; Tong D; Kong Q; Zhou J
Cell Mol Biol Lett; 2019; 24():26. PubMed ID: 30988676
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis.
Zhu L; Wang A; Gao M; Duan X; Li Z
Cancer Cell Int; 2020; 20():145. PubMed ID: 32377170
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis.
Xiao Y; Bao Y; Tang L; Wang L
J Orthop Surg Res; 2019 Aug; 14(1):247. PubMed ID: 31387631
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.
Shen MY; Zhou GR; -Y Zhang Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG/miR-506-3p/TGFB1 axis.
Li S; Hu X; Yu S; Yi P; Chen R; Huang Z; Huang Y; Huang Y; Zhou R; Fan X
Cancer Sci; 2023 Feb; 114(2):504-520. PubMed ID: 36169092
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
15. MIR4435-2HG: A Tumor-associated Long Non-coding RNA.
Zhao F; Liu Y; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(25):2043-2051. PubMed ID: 35674305
[TBL] [Abstract][Full Text] [Related]
16. MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells.
Yu M; Yi Z; Chen S; Chen X; Xie X
Folia Histochem Cytobiol; 2022; 60(2):191-202. PubMed ID: 35730423
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling.
Wang H; Wu M; Lu Y; He K; Cai X; Yu X; Lu J; Teng L
Aging (Albany NY); 2019 Sep; 11(17):6657-6673. PubMed ID: 31484163
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.
Qian H; Chen L; Huang J; Wang X; Ma S; Cui F; Luo L; Ling L; Luo K; Zheng G
J Mol Med (Berl); 2018 Aug; 96(8):753-764. PubMed ID: 29872866
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MIR4435-2HG functions as a ceRNA against miR-125a-5p and promotes neuroglioma development by upregulating TAZ.
Shen W; Zhang J; Pan Y; Jin Y
J Clin Lab Anal; 2021 Dec; 35(12):e24066. PubMed ID: 34714963
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
Front Oncol; 2021; 11():661288. PubMed ID: 34532282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
